We’re so happy to hear the good news that Mr. Trebek is improving after starting immunotherapy for pancreatic cancer. He was diagnosed in early 2019 with pancreatic cancer…and it has been a long, challenging road so far.
But he’s now seeing excellent results thanks to this innovative treatment.
CTOAM was the first in Canada to use immunotherapy!
Did you know that we’ve been using immunotherapy for many years now? In fact, CTOAM was the first in Canada to use immunotherapy to treat stage 4 metastatic melanoma in this groundbreaking case.
That was now over 5 years ago, and Joan is still in full remission! Joan was even able to get her treatments fully covered by her insurance because of the data we provided her and her oncologist with.
You can read Joan’s personal interview about how she and her family dealt with cancer.
What cancer types does it work for?
We have more good news for you: Immunotherapy can work for many different cancer types!
You can hear our cancer expert Alex Rolland explain more in the video below.
Can immunotherapy work for you?
Reach out to us and we’ll help you find out!
You can apply for a free 30 minute strategy session with our cancer care specialists to get the ball rolling: Sign up for a Free Strategy Session
Our spots for this week are already taken, but there are more open next week. During your session we’ll ensure you get all the info you need to make the best choices for yourself and feel more confident in your cancer care.
It’s important to know that the most effective time to start the right targeted treatment is as early as possible.
Yes, we can – and DO! – help people at stage IV (as with Joan and many other patients) but you will have the absolute best chance at kicking cancer to the curb the sooner you start with Precision Oncology. We want you to be able to move on with your life and get back to ‘normal’ asap. That’s what we’re here to help you do.
If you have any questions, email us anytime. We are thinking of you.on August 5, 2020
Tags: Cancer Care, Cancer Research, Immunotherapy, Precision Oncology, Targeted Treatment
Share your thoughts